News
“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.
Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...
1don MSN
FDA considering pulling authorization of Pfizer’s COVID-19 vaccine for healthy children under 5
The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...
The announcement by Robert F. Kennedy Jr. is a major setback for the sector, as the technology has proven effective against ...
(Alliance News) - Baillie Gifford US Growth Trust PLC on Tuesday announced that it outperformed the S&P index in its financial year, as it expects the year ahead to present "significant opportunities" ...
The vaccine was previously available for these children under an Emergency Use Authorization, Moderna noted in a July 10 press release.
4d
Zacks Investment Research on MSNMerck Stock Down 4% Since Q2 Results: How to Play the Stock
Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...
Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.
Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...
RSV vaccine recommended for adults 60+ with health issues, infants under 19 months, and all healthy adults 75+. Helps prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results